Jan 3, 2023 by James Halley3 Top U.S. Stocks to Watch in JanuaryThese companies make everyday products and deliver above-average dividends.
Jan 2, 2023 by James HalleyBetter Large-Cap Buy: Roche Holding or Gilead Sciences Stock?Which of these companies is better able to replace declining COVID-19-related sales?
Dec 31, 2022 by James Halley2 Medical Stocks to Watch Heading Into 2023The two healthcare companies easily outdid the S&P 500 this year.
Dec 31, 2022 by James Halley2 Cannabis Stocks on the Rise With Next to No CompetitionThese cannabis real estate investment trusts are growing.
Dec 30, 2022 by James HalleyWhy Summit Therapeutics Shares Soared This WeekThe clinical-stage biopharma stock has been rising all year.
Dec 29, 2022 by James HalleyWhy Shares of Compugen Rose on ThursdayThe clinical-stage biotech retreated a bit from one of its biggest days in a while.
Dec 29, 2022 by James HalleyWhy Shares of Ocugen Jumped ThursdayCould short-sellers be enacting a squeeze?
Dec 27, 2022 by James HalleyCould CRISPR Therapeutics Help You Become a Millionaire?The gene-editing stock still has plenty of promise.
Dec 26, 2022 by James Halley3 Medical Dividend Stocks That Hit the Sweet SpotThese three offer high dividend yields and consistent revenue growth.
Dec 25, 2022 by James Halley2 Top Biotech Stocks to Buy for the Long HaulThese mid-cap biotechs are solid long-term choices.
Dec 24, 2022 by James Halley3 Under-the-Radar Biotech Stocks to Buy in 2022The attraction of all three biotech stocks is their potential.
Dec 24, 2022 by James Halley2 Healthcare Stocks You Can Buy and Hold for the Next DecadeThese companies are safe havens during tough times, with above-average dividends.
Dec 22, 2022 by James Halley2 No-Brainer Biotech Stocks to Buy Right NowVertex Therapeutics and Amgen have the building blocks for long-term success.
Dec 21, 2022 by James Halley2 Mammoth Stocks With Dividends to Buy Before 2022 EndsBlue chip healthcare stocks Johnson & Johnson and Cigna are always in season.
Dec 18, 2022 by James HalleyAre These Multibillion-Dollar Vaccine Stocks Still a Buy?Moderna and Merck are up on the news regarding their melanoma cancer vaccine.
Dec 17, 2022 by James HalleyGot $500? Consider These 2 Cathie Wood Bargain Stocks.These two growth stocks should benefit from long-term tailwinds.
Dec 16, 2022 by James HalleyWhich Is the Better Buy: Vertex or Invitae?Is Vertex worth its lofty valuation compared to Invitae?
Dec 16, 2022 by James HalleyMeme Stocks That Are Actually Solid Long-Term PicksMeme stocks aren't inherently risky.
Dec 16, 2022 by James Halley2 Dividend Stocks That Could Double Your Return in 10 YearsBoth companies should hurdle their patent cliff concerns.
Dec 15, 2022 by James HalleyWhy BioXCel Therapeutics Stock Jumped This WeekA couple of analysts recently upgraded their views on the biotech stock.
